Markus Hildinger

2.7k total citations
31 papers, 2.2k citations indexed

About

Markus Hildinger is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Markus Hildinger has authored 31 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 22 papers in Genetics and 8 papers in Oncology. Recurrent topics in Markus Hildinger's work include Virus-based gene therapy research (22 papers), RNA Interference and Gene Delivery (13 papers) and Viral Infectious Diseases and Gene Expression in Insects (8 papers). Markus Hildinger is often cited by papers focused on Virus-based gene therapy research (22 papers), RNA Interference and Gene Delivery (13 papers) and Viral Infectious Diseases and Gene Expression in Insects (8 papers). Markus Hildinger collaborates with scholars based in Germany, United States and Switzerland. Markus Hildinger's co-authors include Alberto Auricchio, James M. Wilson, Guangping Gao, Erin E. O’Connor, Florian Μ. Wurm, Gaurav Backliwal, Lili Wang, Wolfram Ostertag, Christopher Baum and Narendra Chirmule and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Investigation and The Journal of Immunology.

In The Last Decade

Markus Hildinger

31 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markus Hildinger Germany 23 1.7k 1.3k 411 259 213 31 2.2k
Karola Rittner France 18 1.4k 0.8× 1.0k 0.8× 340 0.8× 245 0.9× 189 0.9× 34 1.9k
Dea Nagy United States 15 2.2k 1.3× 1.9k 1.4× 637 1.5× 346 1.3× 321 1.5× 22 3.3k
Steven J. Howe United Kingdom 27 1.9k 1.1× 1.6k 1.2× 532 1.3× 206 0.8× 146 0.7× 48 2.5k
Dinko Valerio Netherlands 26 1.1k 0.7× 1.1k 0.8× 611 1.5× 216 0.8× 181 0.8× 56 1.9k
Cynthia C. Bartholomae Germany 20 2.5k 1.5× 2.0k 1.5× 673 1.6× 215 0.8× 155 0.7× 33 3.0k
David M. Markusic United States 26 1.5k 0.9× 1.4k 1.1× 641 1.6× 242 0.9× 236 1.1× 54 2.4k
S. Kaye Spratt United States 18 1.6k 1.0× 623 0.5× 270 0.7× 167 0.6× 122 0.6× 24 2.2k
Brian Tomkowicz United States 17 988 0.6× 508 0.4× 345 0.8× 184 0.7× 143 0.7× 22 1.8k
Richard Surosky United States 20 2.2k 1.3× 1.1k 0.8× 369 0.9× 247 1.0× 227 1.1× 33 2.8k
Claudio Mussolino Germany 22 2.6k 1.6× 909 0.7× 292 0.7× 117 0.5× 252 1.2× 55 3.0k

Countries citing papers authored by Markus Hildinger

Since Specialization
Citations

This map shows the geographic impact of Markus Hildinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Hildinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Hildinger more than expected).

Fields of papers citing papers by Markus Hildinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Hildinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Hildinger. The network helps show where Markus Hildinger may publish in the future.

Co-authorship network of co-authors of Markus Hildinger

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Hildinger. A scholar is included among the top collaborators of Markus Hildinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Hildinger. Markus Hildinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Backliwal, Gaurav, et al.. (2008). Valproic acid: A viable alternative to sodium butyrate for enhancing protein expression in mammalian cell cultures. Biotechnology and Bioengineering. 101(1). 182–189. 139 indexed citations
3.
Backliwal, Gaurav, et al.. (2008). Coexpression of acidic fibroblast growth factor enhances specific productivity and antibody titers in transiently transfected HEK293 cells. New Biotechnology. 25(2-3). 162–166. 23 indexed citations
4.
O’Reilly, Mary, Arpad Palfi, Naomi Chadderton, et al.. (2007). RNA Interference–Mediated Suppression and Replacement of Human Rhodopsin In Vivo. The American Journal of Human Genetics. 81(1). 127–135. 143 indexed citations
5.
Backliwal, Gaurav, et al.. (2007). High‐density transfection with HEK‐293 cells allows doubling of transient titers and removes need for a priori DNA complex formation with PEI. Biotechnology and Bioengineering. 99(3). 721–727. 122 indexed citations
6.
Hildinger, Markus & Alberto Auricchio. (2004). Advances in AAV-mediated gene transfer for the treatment of inherited disorders. European Journal of Human Genetics. 12(4). 263–271. 30 indexed citations
7.
Čmejlová, Jana, Markus Hildinger, Radek Čmejla, et al.. (2003). Impact of splice-site mutations of the human MDR1 cDNA on its stability and expression following retroviral gene transfer. Gene Therapy. 10(12). 1061–1065. 8 indexed citations
8.
Auricchio, Alberto, Paul D. Acton, Markus Hildinger, et al.. (2003). In Vivo Quantitative Noninvasive Imaging of Gene Transfer by Single-Photon Emission Computerized Tomography. Human Gene Therapy. 14(3). 255–261. 26 indexed citations
9.
Auricchio, Alberto, Erin O’Connor, Daniel E. Weiner, et al.. (2002). Noninvasive gene transfer to the lung for systemic delivery of therapeutic proteins. Journal of Clinical Investigation. 110(4). 499–504. 20 indexed citations
10.
Rappa, Germana, Aurelio Lorico, Markus Hildinger, Øystein Fodstad, & Christopher Baum. (2001). Novel Bicistronic Retroviral Vector Expressing γ -Glutamylcysteine Synthetase and the Multidrug Resistance Protein 1 (MRP1) Protects Cells from MRP1-Effluxed Drugs and Alkylating Agents. Human Gene Therapy. 12(14). 1785–1796. 17 indexed citations
11.
Hildinger, Markus, Matthias T. Dittmar, Boris Fehse, et al.. (2001). Membrane-Anchored Peptide Inhibits Human Immunodeficiency Virus Entry. Journal of Virology. 75(6). 3038–3042. 94 indexed citations
12.
Auricchio, Alberto, Erin E. O’Connor, Markus Hildinger, & James M. Wilson. (2001). A Single-Step Affinity Column for Purification of Serotype-5 Based Adeno-associated Viral Vectors. Molecular Therapy. 4(4). 372–374. 77 indexed citations
13.
Kuehlcke, Klaus, Bernhard Schiedlmeier, Markus Hildinger, et al.. (2001). Improved post-transcriptional processing of an MDR1 retrovirus elevates expression of multidrug resistance in primary human hematopoietic cells. Gene Therapy. 8(3). 239–246. 35 indexed citations
14.
Schambach, Axel, et al.. (2000). Context Dependence of Different Modules for Posttranscriptional Enhancement of Gene Expression from Retroviral Vectors. Molecular Therapy. 2(5). 435–445. 165 indexed citations
15.
Hildinger, Markus, Wolfgang Bohn, Boris Fehse, et al.. (1999). Bicistronic retroviral vectors for combining myeloprotection with cell-surface marking. Gene Therapy. 6(7). 1222–1230. 22 indexed citations
16.
17.
Hildinger, Markus, Boris Fehse, Susanna Hegewisch‐Becker, et al.. (1998). Dominant Selection of Hematopoietic Progenitor Cells with Retroviral MDR1 Co-Expression Vectors. Human Gene Therapy. 9(1). 33–42. 47 indexed citations
18.
Hildinger, Markus, et al.. (1998). FMEV vectors: both retroviral long terminal repeat and leader are important for high expression in transduced hematopoietic cells. Gene Therapy. 5(11). 1575–1579. 36 indexed citations
19.
Hunt, Nicholas H., Markus Hildinger, Hans‐Georg Eckert, et al.. (1998). Cis-Active Elements of Friend Spleen Focus-Forming Virus: From Disease Induction to Disease Prevention. Acta Haematologica. 99(3). 156–164. 7 indexed citations
20.
Baum, Christel, H. G. Eckert, M Stockschläder, et al.. (1996). Improved Retroviral Vectors for Hematopoietic Stem Cell Protection and In Vivo Selection. Journal of Hematotherapy. 5(4). 323–329. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karola Rittner Breakdown of academic impact, for papers by Dea Nagy Breakdown of academic impact, for papers by Steven J. Howe Breakdown of academic impact, for papers by Dinko Valerio Breakdown of academic impact, for papers by Cynthia C. Bartholomae Breakdown of academic impact, for papers by David M. Markusic Breakdown of academic impact, for papers by S. Kaye Spratt Breakdown of academic impact, for papers by Brian Tomkowicz Breakdown of academic impact, for papers by Richard Surosky Breakdown of academic impact, for papers by Claudio Mussolino
Rankless by CCL
2026